Genex Pharmaceutical, Inc. (GENX)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Oct 29, 2026
Genex Pharmaceutical Company Description
Genex Pharmaceutical, Inc. produces and distributes Reconstituted Bone Xenograft (RBX) in the People’s Republic of China.
The RBX is a medical device that accelerates bone healing. The company distributes its medical devices to approximately 500 hospitals, as well as to other medical device customers.
Genex Pharmaceutical, Inc. was founded in 2003 and is headquartered in Tianjin, the People’s Republic of China.
Genex Pharmaceutical, Inc.
| Country | United States |
| Founded | 2003 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 86 |
| CEO | Fuzhi Song |
Contact Details
Address: 1801 Guangyin Building Tianjin, 300074 China | |
| Phone | 86 22 2337 0440 |
Stock Details
| Ticker Symbol | GENX |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US37227T1051 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Fuzhi Song | Chairman, Chief Executive Officer, President and Chairman of Zhongjin Biology Development Co. Ltd |
| Shuli Zhang CPA, CPV, CTA | Chief Financial Officer, Principal Accounting Officer, Treasurer and CFO of Zhongjin |